Burden of preschool wheeze and progression to asthma in the UK: Population-based cohort 2007 to 2017

被引:44
作者
Bloom, Chloe I. [1 ]
Franklin, Courtney [2 ]
Bush, Andrew [1 ]
Saglani, Sejal [1 ]
Quint, Jennifer K. [1 ]
机构
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
[2] London Sch Hyg & Trop Med, London, England
基金
英国医学研究理事会;
关键词
Preschool; wheeze; children; asthma; rhinovirus; month; RESPIRATORY-SYNCYTIAL-VIRUS; 1ST; 6; YEARS; CHILDHOOD ASTHMA; EARLY-LIFE; RHINOVIRUS ILLNESSES; PRETERM INFANTS; CHILDREN; RISK; ALLERGY; EXACERBATIONS;
D O I
10.1016/j.jaci.2020.12.643
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Wheeze is one of the most common symptoms of preschool children (age 1-5 years), yet we have little understanding of the burden in the United Kingdom. Objectives: We sought to determine prevalence and pattern of physician-confirmed preschool wheeze, related health care utilization, and factors associated with progression to school-age asthma. Methods: We used nationally representative primary and secondary care electronic medical records between 2007 and 2017 to identify preschool children with wheeze. Factors associated with asthma progression were identified in a nested cohort of children with follow-up from age 1 to 2 years, until at least age 8 years. Results: From 1,021,624 preschool children, 69,261 were identified with wheeze. Prevalence of preschool wheeze was 7.7% in 2017. Wheeze events were lowest in August and highest in late-autumn/early-winter. During median follow-up of 2 years (interquartile range, 1.2-4.0 years), 15.8% attended an emergency department, and 13.9% had a hospital admission, for a respiratory disorder. The nested cohort with prolonged follow-up identified 15,085 children; 35.5% progressed to asthma between age 5 and 8 years. Of children with preschool wheeze, without an asthma diagnosis, 34.9% were prescribed inhaled corticosteroids and 15.6% oral corticosteroids. The factors most strongly associated with progression to asthma were wheeze frequency and severity, atopy, prematurity, maternal asthma severity, and first reported wheeze event occurring in September. Conclusions: Preschool wheeze causes considerable health care burden, and a large number of children are prescribed asthma medication and have unplanned secondary care visits. Multiple factors influence progression to asthma, including first wheeze event occurring in September. (J Allergy Clin Immunol 2021;147:1949-58.)
引用
收藏
页码:1949 / 1958
页数:10
相关论文
共 59 条
[41]   Rhinovirus-induced first wheezing episode predicts atopic but not nonatopic asthma at school age [J].
Lukkarinen, Minna ;
Koistinen, Annamari ;
Turunen, Riitta ;
Lehtinen, Pasi ;
Vuorinen, Tytti ;
Jartti, Tuomas .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (04) :988-995
[42]   Control and severity of asthma during pregnancy are associated with asthma incidence in offspring: two-stage case-control study [J].
Martel, M-J. ;
Rey, E. ;
Beauchesne, M-F. ;
Malo, J-L. ;
Perreault, S. ;
Forget, A. ;
Blais, L. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (03) :579-587
[43]   ASTHMA AND WHEEZING IN THE FIRST 6 YEARS OF LIFE [J].
MARTINEZ, FD ;
WRIGHT, AL ;
TAUSSIG, LM ;
HOLBERG, CJ ;
HALONEN, M ;
MORGAN, WJ ;
BEAN, J ;
BIANCHI, H ;
CURTISS, J ;
EY, J ;
SANGUINETI, A ;
SMITH, B ;
VONDRAK, T ;
WEST, N ;
MCLELLAN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (03) :133-138
[44]   Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database [J].
Minassian, Caroline ;
Williams, Rachael ;
Meeraus, Wilhelmine H. ;
Smeeth, Liam ;
Campbell, Oona M. R. ;
Thomas, Sara L. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (07) :923-933
[45]  
Mochizuki H, 2017, AM J RESP CRIT CARE, V196, P29, DOI [10.1164/rccm.201609-1812OC, 10.1164/rccm.201609-1812oc]
[46]   Validation of asthma recording in the Clinical Practice Research Datalink (CPRD) [J].
Nissen, Francis ;
Morales, Daniel R. ;
Mullerova, Hana ;
Smeeth, Liam ;
Douglas, Ian J. ;
Quint, Jennifer K. .
BMJ OPEN, 2017, 7 (08)
[47]   Promising approaches for the treatment and prevention of viral respiratory illnesses [J].
Papadopoulos, Nikolaos G. ;
Megremis, Spyridon ;
Kitsioulis, Nikolaos A. ;
Vangelatou, Olympia ;
West, Peter ;
Xepapadaki, Paraskevi .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (04) :921-932
[48]   The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence [J].
Perry, Richard ;
Braileanu, George ;
Palmer, Thomas ;
Stevens, Paul .
PHARMACOECONOMICS, 2019, 37 (02) :155-167
[49]   Rhinovirus vaccination: the case in favour [J].
Rohde, G. G. U. .
EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (01) :3-4
[50]   Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial [J].
Scheltema, Nienke M. ;
Nibbelke, Elisabeth E. ;
Pouw, Juliette ;
Blanken, Maarten O. ;
Rovers, Maroeska M. ;
Naaktgeboren, Christiana A. ;
Mazur, Natalie I. ;
Wildenbeest, Joanne G. ;
van der Ent, Cornelis K. ;
Bont, Louis J. .
LANCET RESPIRATORY MEDICINE, 2018, 6 (04) :257-264